|
|
||||||||
Drug Monitoring and Toxicology |
1
Division of Forensic Toxicology, Office of the Armed Forces Medical Examiner, Armed Forces Institute of Pathology, Rockville, MD 20850.
a Address correspondence to this author at: Forensic Toxicology, AFIP Annex, 1413 Research Blvd., Rockville, MD 20850. Fax 301-319-0628; e-mail paul{at}email.afip.osd.mil.
A sensitive method is described to detect isolysergic acid diethylamide (iso-LSD) in urine. The compound was extracted from urine and converted to a C-8 carbanion by sodium ethoxide in ethanol. Protonation of the carbanion by water selectively produced LSD. The conversion of iso-LSD to LSD was almost quantitative (98%). The product was purified by solid-phase fractionation and acidbase separation techniques. The trimethylsilyl derivative of LSD was detected by a gas chro-matographymass spectrometry method. The overall recovery of the procedure was approximately 69%. Quantification of iso-LSD was linear over the concentration range 502000 ng/L. In specimen analysis, iso-LSD was detected when the LSD concentration was below the limit of the detection (50 ng/L) of the procedure. Because iso-LSD is a byproduct of illicit preparation of LSD, presence of iso-LSD in urine is an indication of LSD use.
The following articles in journals at HighWire Press have cited this article:
![]() |
F.-L. Sauvage, J.-M. Gaulier, G. Lachatre, and P. Marquet Pitfalls and Prevention Strategies for Liquid Chromatography-Tandem Mass Spectrometry in the Selected Reaction- Monitoring Mode for Drug Analysis Clin. Chem., September 1, 2008; 54(9): 1519 - 1527. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Skopp, L. Potsch, R. Mattern, and R. Aderjan Short-Term Stability of Lysergic Acid Diethylamide (LSD), N-Desmethyl-LSD, and 2-Oxo-3-hydroxy-LSD in Urine, Assessed by Liquid Chromatography-Tandem Mass Spectrometry Clin. Chem., September 1, 2002; 48(9): 1615 - 1618. [Full Text] [PDF] |
||||
![]() |
P. D. Anderson, K. Naik, C. Kinemond, and A. ImObersteg Forensic Testing for Drugs of Abuse Journal of Pharmacy Practice, June 1, 2000; 13(3): 226 - 235. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |